Novartis Pharmaceuticals Issues Public Comment on FDA Notice
2021-11-23
zz-Public Comments2021-11-23
Targeted News Service
WASHINGTON, Nov. 23 -- Nicole Mahoney, executive director for U.S. regulatory policy and intelligence and regulatory affairs at Novartis Pharmaceuticals Corp., Basel, Switzerland, has issued a public . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Nov. 23 -- Nicole Mahoney, executive director for U.S. regulatory policy and intelligence and regulatory affairs at Novartis Pharmaceuticals Corp., Basel, Switzerland, has issued a public . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2021